Responding to Blood-Borne Viruses in Australian Prisons
Published: 17 October 2017
Australian prisons are a priority setting to reduce the incidence and burden of hepatitis B hepatitis C and HIV. With high prevalence rates of hep B and hep C in prisons, Australia must ensure the deployment of proven prevention strategies, effective health monitoring and systems for ready access to treatment across Australia’s prison network, including remand centres and other correctional facilities.
This paper prepared by Hepatitis Australia in partnership with AIVL, AFAO and NAPWHA explores the Australian response to blood borne viruses in Australian prisons and puts forward initial strategies to pave the way to a more effective and equitable approach for the prevention, management and treatment of BBVs in Australia’s prisons.